Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD Prophylaxis

NCT06525519 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: ATLG
DRUG: ATLG

Sponsor

Institute of Hematology & Blood Diseases Hospital, China